Rough mutants (or, more precisely, R forms as defined immunologically1) of Salmonella produce cell wall lipopolysaccharide (LPS) containing as monosaccharide units only glucose, galactose, heptose, and glucosamine,2 and have none of the 0-antigenic specificities of the parent strain. By contrast, smooth strains (S forms) have specific 0 antigens and produce LPS which in many 0 groups contain additional kinds of sugar,3 in some instances proved to be determinants of 0-antigenic factors.4 It is believed2' 5, 6 that R forms have defects in the synthesis of LPS, so that they synthesize incomplete LPS, corresponding to the central "core" of S-type LPS and totally lacking the "S-specific side-chain" in which the S-specific sugars,7 if any, are located. Furthermore, Beckmann et al.8 have found that there are two antigenically different kinds of R forms, RI and RI,; RI, forms are believed to synthesize LPS lacking only the S-specific side-chain,5'6 whereas the LPS of RI strains is less complete than RI, LPS and probably lacks one or more of the deeper monosaccharide units in addition to the S-specific side-chain.5 6 Salmonella T forms, once supposed intermediate between S and R forms,9 produce LPS resembling that of R form in respect of sugar composition;10 the biochemical basis of the smooth colonial morphology and saline stability which differentiate the T form from the R form is unknown.
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We here report salmonella recombinants and mutants of a form intermediate between S and R both in biological properties and in LPS composition, and propose the hypothesis that in this form, which we call semirough or SR, only the innermost portion of the normal S-specific side-chain is attached to the RI, core LPS. Table 1 lists the strains used and their origins. These semirough strains were first encountered as recombinants in certain crosses between salmonella S strains of different 0 groups. An Hfr strain' of S. abony (group B; 0-antigen, 4, 5, 12; S-specific sugars, mannose, rhamnose, and abequose) were crossed to an F-strain of S.
Montevideo (group Cj; 0-antigen, 6, 7; S-specific sugar, mannose). When recoinbinants with the his+ locus"la from the donor were selected, it was found that a few of them expressed the 0-antigens 4,5,12 of the donor strain; but about two thirds of the his+ recombinants differed serologically from either parent and formed a homogeneous group we term SR. Similar recombinants were obtained in crosses of a S. abony Hfr with a S. takoradi F-(group C2; 0-antigen,6,8; S-specific sugars, mannose, rhamnose, and abequose), and as a rare class, in crosses of a S. montevideo Hfr to a S. typhimurium F-(group B) strain. The detailed results of these crosses will be published elsewhere. '2 In their cultural and serological properties (Table 2) , the SR recombinants were intermediate between S and R forms, giving smooth-looking colonies but growing with deposit in broth and being unstable in saline suspensions. This instability made it difficult to determine the presence of 0-antigen factors. However, the presence of 04, indicated by slide agglutination, has been confirmed by the ability of one SR recombinant to evoke anti-04 antibody in the rabbit; SR recombinants also absorbed anti-04 serum but their absorbing capacity was poor, which suggests that they have much less factor 04 than S forms of group B salmonella. 0-5 was tested by absorption of monofactor anti-0-5 serum by SR bacteria, and by quantitative complement fixation testl6 using the same serum and SR LPS; some SR recombinants had no activity, and others had weak 0-5 activity. The presence of 0-12 was uncertain; the failure of SR strains to adsorb phage P22 suggests its absence.'7 LPS from several SR strains did not fix complement when incubated with anti-Ri antibody (Fig. 1) . LPS from an SR recombinant precipitated much less antibody from an anti4,5,12 serum than did a 4,5,12 LPS. No 0-6 or 0-7 specificity was detected in any SR recombinant.
The sugar composition of the LPS of the SR recombinants and of their S parent strains, and, for comparison, of R and T variants of group B salmonella, is recorded FIG. 1.-System for complement fixations contained, in a total volume of 1.2 ml, 0.1 ml of anti-Rii serum (diluted 1:500), antigen, and 0.2 ml of guinea pig complement (diluted 1:250).
After overnight incubation at 0WC, 0.2 ml of sensitized sheep red blood cells (= 107 cells) were added, and hemolysis was measured after 1 hr at 370C. LPS prepared by phenol extraction (see legend to Table 3 ) was used as antigen. One unit of LPS is the amount which contains 0.13 mismole of heptose. LPS and SH835 gave results similar to SH805 and SL901, and LPS from two other Ru mutants gave results similar to TV119.
in Table 3 . The quantitative results for sugars are expressed as moles per two moles of heptose, because heptose is present only in the "backbone" of LPS18 and because there is probably one side-chain per two heptose units.'9 LPS preparations were also analyzed qualitatively by thin layer chromatography on cellulose after hydrolysis with N H2SO4. The analyses of the S, R, and T forms agreed with earlier reports.2 ' 3, 6 No mannose, rhamnose, or abequose was detected in the LPS'of the R and T forms. The LPS of the group C, S form parent contained much mannose but no rhamnose or abequose; its high content of hexose suggests that 0-6,7 LPS has long S-specific side-chains containing much hexose. The LPS of the S form parent of group B contained much mannose, rhamnose, and abequose; if, as is generally believed, the S-specific side-chain in group B is made up of "repeat units,"25 each containing one mole each of mannose, rhamnose, galactose, and abequose (and perhaps also one glucose)26 (cf. Fig. 2 ), the average number of "repeat units" per chain was not less than three or four. The LPS of the SR recombinants contained mannose, rhamnose, and abequose, but in very much smaller amounts than the LPS of S form of group B. If the assumed repeat unit is present in SR LPS, the average number of repeat units per two heptose units, or per side chain, is only 0.3-0.7 ;27 one quarter to one thirteenth the average number in S form LPS. The side-chains of the SR LPS might be of uniform length and composition; or there might be a few S-specific side-chains of normal length and many R "stubs," totally lacking any S-specific side-chains. Since such "stubs" would presumably react with anti-R11 antibody, the absence of RI, specificity in SR LPS (Fig. 1) is strong evidence against the latter notion. RI forms, which have no defect in the synthesis of S-specific side-chain itself, are known to synthesize a soluble hapten containing all the S-specific sugars.8 Such a hapten was not found in the extracts of SR recombinants, a finding consistent with the assumption that they have a defect preventing them from completing the synthesis of a normal S-specific side-chain.
Perhaps the SR recombinants lack one or more enzymes which in S-form salmonella of group B are concerned with the elongation of the 4,12 side-chain27a after the attachment to the R core of the most proximal units of the side-chain-the small amount of mannose, rhamnose, and abequose in the SR LPS representing these proximal units.28 Our genetic interpretation of the appearance of SR recombinants in crosses of group B and group C salmonella is that the group C parent lacks the genes for several of the enzymes needed for the synthesis of 4,12 side-chain, including the gene(s) for its elongation; that in the group B parent all the genes missing in group C parent, except a gene or genes for elongation, are closely linked to his; and that in consequence many of the group C recipients acquiring his+ from the group B donor acquire also all the genes missing in the group C parent except one or more unlinked elongation genes, and at the same time lose all or some of the genes they had for the synthesis of group C 0-antigens. (Table 3) . We suppose them to be SR mutants, resulting from mutational loss of the same elongation enzyme(s) as are missing in the SR recombinants. In two SR mutants of this class the site of mutation mapped between gal and try, i.e., remote from his,3' a finding consistent with our interpretation of group B by -group C crosses discussed already. The other group of mutants, class D, including the P22-resistant mutant st/22 of Yamamoto and Anderson,14 differ from SR recombinants and the class C mutants in phage resistance pattern30 and in some cultural characters, although the composition of LPS from one of them resembled that of SR LPS (Table 3 ). In two mutants of class D, the site of mutation was near str, i.e., remote from both his and from the gal-try region.3 In contrast to the LPS of SR recombinants and class C mutants, their LPS reacted, in complement fixation test, with anti-Rii serum almost as strongly as an Rii LPS did. Possibly their LPS has many R "stubs," and side-chains which may be of normal length but are fewer in number than in S-form LPS.
No enzyme defect has yet been established in any of the SR strains. However, we can easily envisage one sort of enzyme which will be needed for the elongation of the 4,12 side-chain. Recent studies32 33 suggest that the most proximal part of the S-specific side-chain contains the same sequence of sugars as the remainder, attached to N-acetylglucosamine, the terminal sugar of the R "stub" of RI, LPS. If the Sspecific side-chain of group B salmonella consists of a repeat unit, probably of the structure shown in Figure 2 , and if the sugar units are added one by one, then one enzyme will be needed to attach the most proximal sugar of the S-specific side-chain (ZI of Fig. 2) , be it rhamnose, galactose, or mannose, to the N-acetylglucosamine, and presumably another enzyme will be required to add the second (ZIn of Fig. 2) and subsequent units of this sugar, since they must now be attached not to N-acetylglucosamine but to the appropriate sugar of the galactosyl-mannosyl-rhamnose repeat unit. Lack of the latter enzyme would result in the addition of only one repeat unit to each terminal N-acetylglucosamine and would account for the quantitative sugar analyses of LPS from SR strains.
So far as we are aware, the presence of the salmonella SR form as here defined has not previously been established. Robbins and Uchida36 recently reported that a mutant form of the phage e15 converted S. anatum to a form with an LPS containing abnormally few S-specific determinant groups. But, unlike the LPS of SR forms, this LPS apparently contains two or more repeat units per two heptose units. Finally, it should be stressed that the explanation discussed in this paper is still tentative and many more genetic, immunological, and biochemical studies are necessary. Such studies are in progress. The immunological hypothesis of graft rejection is founded upon the second-set phenomenon:' recipient animals which have already rejected grafts reject subsequent donor grafts in accelerated fashion. According to this hypothesis, "transplantation antigens" are defined as donor-specific substances which are "released" by the graft and thereby sensitize the recipient. Operationally, the activity of tissue extracts as transplantation antigens may be demonstrated by their ability to induce more or less donor-specific sensitization such that subsequent transplants are rejected in accelerated fashion. 2 Chemical analyses of extracts capable of inducing skin sensitization have suggested that their antigenicity depended upon, or was associated with, desoxyribonucleoproteins,2 mucoproteins,3 and/or lipoproteins.4 Recently, five independent groups of investigators4-8 have demonstrated that materials with the bulk properties of lipoproteins function as transplantation antigens in skin-sensitizing,' enhancing,6 and serologic4-8 assays. These preparations (a) were water-insoluble, (b) contained approximately equal amounts of lipide and protein and only small amounts of carbohydrate, (c) were inactivated by organic solvents, and (d) failed to move on electrophoresis at several pH's. Solubilized derivatives of these extracts6 8 retained serologic activity but had lost their sensitizing activity.
A soluble transplantation antigen was prepared from water-lysed tumor cells by Manson et al.9 This antigen was of low potency; it could immunize against donor strain tumor or tail-skin grafts but not against body-skin grafts.
